Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hongchang International Co., Ltd. (HCIL : OTC)

• Company Description    Hongchang International Co Ltd is a holding company mainly engaged in research and development and manufacture a medical product. Hongchang International Co Ltd, formerly known as Heyu Biological Technology Corp, is based in China. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.08 Daily Weekly Monthly 20 Day Moving Average: 34 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: -30.32 52 Week High: $0.50 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -58.75% -59.49% 12 Week -39.78% -45.33% Year To Date -19.59% -28.21%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL ROOM 2409 RONGSHANG BUILDING FUREN AVENUE - FUQING CITY,FU 350300 CHN ph: 86-180-5901-6050 fax: 858-459-1103 ir@pacificwebworks.com https://heyubt.com

• General Corporate Information    Officers Zengqiang Lin - Chief Executive Officer; Chief Financial Officer; Ban Siong Ang - Chairman and Director Qingqing Wang - Board Secretary Zhenzhu Lin - Director Zhenzhu Lin - Director Peer Information Hongchang International Co., Ltd. (BJCT) Hongchang International Co., Ltd. (CADMQ) Hongchang International Co., Ltd. (APNO) Hongchang International Co., Ltd. (UPDC) Hongchang International Co., Ltd. (IMTIQ) Hongchang International Co., Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 42831T202 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/12/25 Share - Related Items Shares Outstanding: Most Recent Split Date: 8.00 (0.10:1) Beta: -30.32 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.20 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 93.95% vs. Previous Quarter: -% ROE 06/30/25 - 0.46 03/31/25 - -0.94 12/31/24 - -1.19 ROA 06/30/25 - 0.32 03/31/25 - -0.64 12/31/24 - -0.83 Current Ratio 06/30/25 - 0.69 03/31/25 - 0.63 12/31/24 - 1.21 Quick Ratio 06/30/25 - 0.68 03/31/25 - 0.62 12/31/24 - 1.21 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -16.50 Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -16.50 Pre-Tax Margin 06/30/25 - 3.38 03/31/25 - -13.79 12/31/24 - -17.26 Book Value 06/30/25 - 0.41 03/31/25 - 0.40 12/31/24 - 0.38 Inventory Turnover 06/30/25 - 8.36 03/31/25 - 2.90 12/31/24 - 2.95 Debt-to-Equity 06/30/25 - 0.15 03/31/25 - 0.16 12/31/24 - 0.17 Debt-to-Capital 06/30/25 - 13.41 03/31/25 - 13.76 12/31/24 - 14.48

Powered by Zacks Investment Research ©